Zobrazeno 1 - 10
of 97
pro vyhledávání: '"Lawrence C. Swayne"'
Autor:
Lawrence C. Swayne
Publikováno v:
Journal of the American College of Radiology : JACR. 15(4)
Autor:
Lawrence C. Swayne
Publikováno v:
Journal of the American College of Radiology. 11:777-780
Although radiologists have kept pace with the dramatic growth of medical imaging during the past two decades through the use of PACS, digital dictation, and 3-dimensional reconstruction, radiology is approaching the point of diminishing returns. As r
Autor:
Lawrence C. Swayne
Publikováno v:
Journal of the American College of Radiology. 2:777-781
Several recent publications in the radiology literature have reported on the growing phenomenon of pay for performance. This potent new business model seeks to reward health care providers with financial incentives for improvements in the performance
Autor:
Gary Williams, Philip E. Crewson, Alan Fask, John D. Fanburg, Helen D. Stelletell, Lawrence C. Swayne
Publikováno v:
American Journal of Roentgenology. 179:21-25
Prompt payment has emerged as a dominant issue in managed care reform, with 47 states passing laws or regulations requiring prompt remuneration for medical services. The New Jersey Prompt-Pay Act, effective on December 28, 1999, requires payment with
Autor:
Lawrence C. Swayne, Thomas J. Smith, Jory G. Magidson, Errol J. Britto, Aaron H. Chevinsky, Ira A. Jacobs
Publikováno v:
Journal of Surgical Oncology. 77:157-164
Background and Objectives Some patients presenting with cutaneous malignant melanoma without palpable adenopathy have regional metastatic disease. The results of a prospective clinical study of γ probe-directed sentinel lymph node (SLN) biopsy are p
Autor:
Malik E. Juweid, Michael Pereira, Lawrence C. Swayne, David M. Goldenberg, George Hajjar, Thomas Herskovic, Samer Suleiman, Robert M. Sharkey, Arnold D. Rubin
Publikováno v:
Cancer. 85:1828-1842
BACKGROUND Monoclonal antibodies (MAbs) against carcinoembryonic antigen (CEA) have been recognized as targeting agents for medullary thyroid carcinoma (MTC). This Phase I/II study was initiated to determine the safety, maximum tolerated dose (MTD),
Autor:
Lawrence C. Swayne, David M. Goldenberg, Malik E. Juweid, Robert M. Sharkey, Robert M. Dunn, Thomas Herskovic, Arnold D. Rubin
Publikováno v:
Gynecologic Oncology. 67:259-271
Objectives. Epithelial ovarian cancer (EOC) is known to produce carcinoembryonic antigen (CEA), and the plasma CEA level is frequently elevated in patients with advanced stage and bulk of tumor. This study reports the results of a phase I therapy tri
Publikováno v:
Surgery. 122:1156-1165
Background. This study examined the utility of using radiolabeled anticarcinoembryonic antigen (CEA) monoclonal antibodies (MAbs) as a noninvasive imaging method to aid in the selection of patients for reoperation after operation for medullary thyroi
Autor:
Thomas M. Behr, Jeffry A. Siegel, Robert M. Dunn, Lawrence C. Swayne, Zhiliang Ying, Hans J. Hansen, Robert M. Sharkey, David M. Goldenberg, Malik E. Juweid
Publikováno v:
Cancer. 78:157-168
BACKGROUND The initial clinical experience with the second-generation, high-affinity, MN-14 immunoglobulin (IgG) anticarcinoembryonic antigen (CEA) monoclonal antibody (MoAb) in patients with CEA-producing tumors was reported previously. A bivalent f
Autor:
Thomas M. Behr, Robert M. Dunn, Thomas Herskovic, Toheed Kamal, Lawrence C. Swayne, A. Rubin, David M. Goldenberg, A. Markowitz, Robert M. Sharkey, Malik E. Juweid, Debra Hanley, Jeffry A. Siegel
Publikováno v:
Journal of Clinical Oncology. 14:1209-1217
PURPOSE This investigation was undertaken to assess the targeting of established and occult medullary thyroid cancer (MTC) with radiolabeled monoclonal antibodies (MAbs) reactive with carcinoembryonic antigen (CEA). PATIENTS AND METHODS Twenty-six as